SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018108
Filing Date
2016-05-06
Accepted
2016-05-05 21:30:28
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20160331.htm 10-Q 1638381
2 EX-10.5 ptla-ex105_9.htm EX-10.5 17020
3 EX-31.1 ptla-ex311_7.htm EX-31.1 9702
4 EX-31.2 ptla-ex312_8.htm EX-31.2 9728
5 EX-32.1 ptla-ex321_6.htm EX-32.1 8816
  Complete submission text file 0001564590-16-018108.txt   5862829

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptla-20160331.xml EX-101.INS 1283584
7 XBRL TAXONOMY EXTENSION SCHEMA ptla-20160331.xsd EX-101.SCH 45253
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20160331_cal.xml EX-101.CAL 36860
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20160331_def.xml EX-101.DEF 135633
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20160331_lab.xml EX-101.LAB 317319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20160331_pre.xml EX-101.PRE 250885
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 161625738
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences